{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:26:51Z","timestamp":1759336011050},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities of China","doi-asserted-by":"crossref","award":["2013ZM0109"],"award-info":[{"award-number":["2013ZM0109"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.humimm.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T17:16:30Z","timestamp":1458407790000},"page":"418-425","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.humimm.2016.03.006_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2016.03.006_b0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10552-010-9504-y","article-title":"Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma","volume":"21","author":"Fernberg","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.humimm.2016.03.006_b0020","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2005-10-4160","article-title":"Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma","volume":"107","author":"Lan","year":"2006","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.humimm.2016.03.006_b0025","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1158\/0008-5472.CAN-06-0324","article-title":"Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.humimm.2016.03.006_b0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgl200","article-title":"Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study","volume":"28","author":"Purdue","year":"2007","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.humimm.2016.03.006_b0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwp383","article-title":"Tumor necrosis factor (TNF) and lymphotoxin-a (LTA) polymorphisms and risk of non-Hodgkin Lymphoma in the InterLymph Consortium","volume":"171","author":"Skibola","year":"2010","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.humimm.2016.03.006_b0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s002620050483","article-title":"A review of the association between interleukin-10 and human B-cell malignancies","volume":"46","author":"Khatri","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.humimm.2016.03.006_b0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2016.03.006_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur. J. Immunogenet."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/1042819021000035590","article-title":"Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to aggressive non-Hodgkin lymphoma","volume":"44","author":"Cunningham","year":"2003","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.humimm.2016.03.006_b0060","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1182\/blood-2003-06-1850","article-title":"Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma","volume":"103","author":"Lech-Maranda","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humimm.2016.03.006_b0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jhep.2006.07.026","article-title":"Interleukin-10-1082GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection","volume":"45","author":"Persico","year":"2006","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.humimm.2016.03.006_b0070","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2004-12-4814","article-title":"The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma","volume":"105","author":"Berglund","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humimm.2016.03.006_b0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.gene.6364337","article-title":"Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk","volume":"7","author":"Nieters","year":"2006","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.gene.6364364","article-title":"The interleukin-10 gene promoter polymorphism 1087AG does not correlate with clinical outcome in non-Hodgkin\u2019s lymphoma","volume":"8","author":"Kube","year":"2007","journal-title":"Genes Immun."},{"issue":"12","key":"10.1016\/j.humimm.2016.03.006_b0085","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1158\/1078-0432.CCR-07-5182","article-title":"Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin\u2019s lymphoma: an exploratory study","volume":"14","author":"Kube","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.humimm.2016.03.006_b0090","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1080\/10428190701615926","article-title":"Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma","volume":"48","author":"Lech-Maranda","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.humimm.2016.03.006_b0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0609.2009.01288.x","article-title":"Genetic variants in immunoregulatory genes and risk for childhood lymphomas","volume":"83","author":"Andrie","year":"2009","journal-title":"Eur. J. Haematol."},{"issue":"7414","key":"10.1016\/j.humimm.2016.03.006_b0100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.humimm.2016.03.006_b0105","first-page":"15","article-title":"Assessing the influence of a single study in the meta-analysis estimate","volume":"8","author":"Tobias","year":"1999","journal-title":"Stata Tech. Bull."},{"issue":"7109","key":"10.1016\/j.humimm.2016.03.006_b0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.humimm.2016.03.006_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/gcc.22028","article-title":"Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia","volume":"52","author":"Lech-Maranda","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.humimm.2016.03.006_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037846","article-title":"Tumor necrosis factor-\u03b1 induced protein 8 polymorphism and risk of non-Hodgkin\u2019s lymphoma in a Chinese population: a case-control study","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.humimm.2016.03.006_b0125","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3109\/10428194.2013.774392","article-title":"Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"54","author":"Yri","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"6","key":"10.1016\/j.humimm.2016.03.006_b0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12185-013-1345-5","article-title":"IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations","volume":"97","author":"Hosgood","year":"2013","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.humimm.2016.03.006_b0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejmhg.2013.09.001","article-title":"Interleukin 10 gene promoter polymorphism and risk of diffuse large B cell lymphoma (DLBCL)","volume":"15","author":"Talaat","year":"2014","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hon.843","article-title":"Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia","volume":"26","author":"Ennas","year":"2008","journal-title":"Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0145","first-page":"154","article-title":"Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography","volume":"16","author":"Guzowski","year":"2005","journal-title":"J. Biomol. Tech."},{"key":"10.1016\/j.humimm.2016.03.006_b0150","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2141.2009.07790.x","article-title":"Common genetic variants in candidate genes and risk of familial lymphoid malignancies","volume":"146","author":"Liang","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s002510050250","article-title":"Mapping the human IL-10 gene and further characterization of the 5\u2032flanking sequence","volume":"46","author":"Eskdale","year":"1997","journal-title":"Immunogenetics"},{"issue":"11","key":"10.1016\/j.humimm.2016.03.006_b0160","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.4049\/jimmunol.148.11.3618","article-title":"Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes","volume":"148","author":"Kim","year":"1992","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1521-6616(03)00214-6","article-title":"Non-Hodgkin\u2019s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter 592 C\/C genotype","volume":"109","author":"Breen","year":"2003","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2016.03.006_b0170","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/blood.V97.6.1796","article-title":"Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis","volume":"97","author":"Guedez","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humimm.2016.03.006_b0175","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood.V85.12.3423.bloodjournal85123423","article-title":"Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma","volume":"85","author":"Masood","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humimm.2016.03.006_b0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000421-200212000-00007","article-title":"Correlation of serum IL-2, IL-6 and IL-10 levels with International Prognostic Index in patients with aggressive non-Hodgkin\u2019s lymphoma","volume":"25","author":"Aydin","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2016.03.006_b0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V97.1.256","article-title":"IL-6 and IL-10 levels in CLL: correlation with phenotypic characteristics and outcome","volume":"97","author":"Fayad","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humimm.2016.03.006_b0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.leu.2403244","article-title":"Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma","volume":"18","author":"Czarneski","year":"2004","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.humimm.2016.03.006_b0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00438-015-1058-y","article-title":"Association of interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis","volume":"290","author":"Zhang","year":"2015","journal-title":"Mol. Genet. Genomics"},{"issue":"2","key":"10.1016\/j.humimm.2016.03.006_b0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gene.2013.01.066","article-title":"Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis","volume":"519","author":"Cao","year":"2013","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.humimm.2016.03.006_b0205","first-page":"4720","article-title":"Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin\u2019s lymphoma risk: a meta-analysis","volume":"7","author":"Dai","year":"2014","journal-title":"Int. J. Clin. Exp. Med."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T08:29:04Z","timestamp":1692260944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0198885916300386"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.03.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}